التفاصيل البيبلوغرافية
| العنوان: |
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. |
| المؤلفون: |
Brahmer, Julie1 brahmju@jhmi.edu, Reckamp, Karen L.2, Baas, Paul3, Crinò, Lucio4, Eberhardt, Wilfried E. E.5,6, Poddubskaya, Elena7, Antonia, Scott8, Pluzanski, Adam9, Vokes, Everett E.10, Holgado, Esther11, Waterhouse, David12, Ready, Neal13, Gainor, Justin14, Frontera, Osvaldo Arén15, Havel, Libor16, Steins, Martin17, Garassino, Marina C.18, Aerts, Joachim G.19, Domine, Manuel20, Paz-Ares, Luis21 |
| المصدر: |
New England Journal of Medicine. 7/9/2015, Vol. 373 Issue 2, p123-135. 13p. |
| مصطلحات موضوعية: |
*LUNG cancer, *DOCETAXEL, *CANCER treatment, *SQUAMOUS cell carcinoma, *CLINICAL trials, *GENETICS |
| مستخلص: |
The article discusses research which compared effectiveness and safety of nivolumab and docetaxel in treating patients with advanced squamous-cell non-small-cell lung cancer (NSCLC). Topics explored include the research participant recruitment and screening process, the nivolumab and docetaxel dosage administered to patients, and the patient outcomes recorded such as tumor response and adverse effects. |
| قاعدة البيانات: |
Academic Search Index |
